Showing results (601-610 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|March 7, 1998
Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 miceM J Ehrke, S Verstovsek, P Ujházy, et al.
Cancer Immunology, Immunotherapy : CII|April 29, 1998
Tumor antigen presentation: changing the rulesT D Armstrong, B A Pulaski, S Ostrand-Rosenberg
Cancer Immunology, Immunotherapy : CII|April 29, 1998
Tumor immunotherapy: cytokines and antigen presentationE M Lord, J G Frelinger
Cancer Immunology, Immunotherapy : CII|April 29, 1998
Immunotherapy of cancer with dendritic-cell-based vaccinesE Gilboa, S K Nair, H K Lyerly
Cancer Immunology, Immunotherapy : CII|May 21, 2015
Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challengeMoniek A de Witte, Guido J J Kierkels, Trudy Straetemans, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2015
Increased CCL17 serum levels are associated with improved survival in advanced melanomaBenjamin Weide, Nicolas Allgaier, Andreas Hector, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2015
Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β -511 is associated with development of cervical carcinomaSankhadeep Dutta, Chandraditya Chakraborty, Ranajit Kumar Mandal, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2015
Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse modelKatie L Powell, Alexandre S Stephens, Stephen J Ralph
Cancer Immunology, Immunotherapy : CII|April 21, 2015
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosisHaiming Yu, Junlan Yang, Shunchang Jiao, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2015
Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancerVladimir Riabov, David Kim, Surmeet Chhina, et al.
Pageof 650